Clinical Trials Logo

Trigeminal Neuralgia clinical trials

View clinical trials related to Trigeminal Neuralgia.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT06129071 Withdrawn - Clinical trials for Trigeminal Neuralgia

Analgesic Effect of Ultrasound Guided Maxillary Nerve Block in Trigeminal Neuralgia

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

This is a study about the dynamics and effects of ultrasound guided maxillary nerve block in trigeminal neuralgia

NCT ID: NCT04353505 Withdrawn - Chronic Migraine Clinical Trials

Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache

Start date: October 2020
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of intra-arterial (IA) delivery of Dexamethasone and Ketorolac into the arteries supplying the sphenopalatine ganglion (SPG) - a collection of neurons that plays an important role in headache disorders - in patients with refractory migraine, cluster headache and trigeminal neuralgia. All patients must fail standard treatments prior to enrollment in the trial.

NCT ID: NCT03637387 Withdrawn - Clinical trials for Trigeminal Neuralgia

802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia

SURGE-2
Start date: March 1, 2023
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to evaluate the efficacy of BIIB074 in treating pain experienced by participants with trigeminal neuralgia (TN). The secondary objectives are to investigate the safety and tolerability of BIIB074 in participants with TN and to evaluate the population pharmacokinetic(s) (PK) of BIIB074.

NCT ID: NCT03374709 Withdrawn - Clinical trials for Trigeminal Neuralgia

Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia

Start date: December 14, 2018
Phase: Phase 4
Study type: Interventional

To evaluate the affect Oxtellar XR (Extended Release) has on neurology patients with trigeminal neuralgia (TN), and if it impacts their quality of life.

NCT ID: NCT03070132 Withdrawn - Clinical trials for Trigeminal Neuralgia

802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia

SURGE-1
Start date: April 19, 2023
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to evaluate the efficacy of BIIB074 in treating pain experienced by participants with trigeminal neuralgia (TN). Secondary objectives of this study are to investigate the safety and tolerability of BIIB074 in participants with TN and to evaluate the population pharmacokinetics (PK) of BIIB074.

NCT ID: NCT01932255 Withdrawn - Clinical trials for Trigeminal Neuralgia

CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap

Start date: October 2013
Phase: N/A
Study type: Observational

Even at centers with very large experience, the risk of cerebrospinal fluid (CSF) leakage in surgery for microvascular decompression is reported up to 3%. Prevention of leakage is important since meningitis may follow. Also, leakage usually means longer hospital stay and increased cost. In case of detected leakage extra sutures may be applied, placement of a lumbar drain may be considered or a revision and improved closure may be attempted. With leakage in the subcutaneous tissue, but not through the skin, a local accumulation causing local symptoms may also occur. In addition to being burdensome and being associated with longer hospital stays with possible revision surgery, such complications are also very costly. The best way to reduce cost and burden, and to improve patient care, is to prevent CSF leakage. The aim of this study is to determine if prophylactic lumbar tap is beneficial for prevention of cerebrospinal fluid leakage following microvascular decompression, by comparison of surgical approaches in 3 geographical areas in the Scandinavian health system. Hypothesis: There is no difference in cerebrospinal fluid leakage between the group subject to prophylactic spinal tap versus the group without prophylactic spinal tap.

NCT ID: NCT01920087 Withdrawn - Clinical trials for Atypical Facial Pain

Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain

AFP
Start date: March 2014
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to test the efficacy of ATNC05 in the treatment of Atypical Facial Pain (AFP), also known as Persistent Idiopathic Facial Pain (PIFP). This research project targets patients with chronic constant facial pain and excludes patients with primarily paroxysmal pain.

NCT ID: NCT00349050 Withdrawn - Pain Clinical Trials

Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception

Start date: July 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to investigate the effects of transcranial magnetic stimulation on pain perception.